Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1999-11-5
pubmed:abstractText
Accumulating evidence indicates that eotaxin plays an integral role in tissue recruitment of eosinophils in humans as well as in animals. To clarify which types of cells are actually important as sources of human eotaxin, we used a specific enzyme-linked immunosorbent assay (ELISA) to compare various types of hemopoietic and nonhemopoietic cells for the ability to produce eotaxin protein. Regardless of various conditioning, we failed to determine any significant eotaxin generation by peripheral leukocytes and vein endothelial cells (less than 20 pg/ml). A small amount of immunoreactive eotaxin was detected in cultures of A549 bronchial epithelial cell line cells. In contrast, dermal fibroblasts were capable of generating extremely high, and potentially biologically relevant, amounts of eotaxin protein (on the order of ng/ml). The eotaxin generation was induced by tumour necrosis factor alpha (TNF-alpha) or IL-4, and the production was drastically increased by combined use of these cytokines. Because fibroblasts are ideally situated within the interstium at the sites of allergic responses, our finding that these cells represent an important cellular source of eotaxin suggests that fibroblast-derived eotaxin may act to regulate eosinophil recruitment in a paracrine fashion.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1043-4666
pubmed:author
pubmed:copyrightInfo
Copyright 1999 Academic Press.
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
751-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10525313-Bronchi, pubmed-meshheading:10525313-Cell Line, pubmed-meshheading:10525313-Chemokine CCL11, pubmed-meshheading:10525313-Chemokines, CC, pubmed-meshheading:10525313-Chemotactic Factors, Eosinophil, pubmed-meshheading:10525313-Cytokines, pubmed-meshheading:10525313-Dermis, pubmed-meshheading:10525313-Dose-Response Relationship, Drug, pubmed-meshheading:10525313-Drug Synergism, pubmed-meshheading:10525313-Endothelium, Vascular, pubmed-meshheading:10525313-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:10525313-Epithelial Cells, pubmed-meshheading:10525313-Fibroblasts, pubmed-meshheading:10525313-Humans, pubmed-meshheading:10525313-Interleukin-4, pubmed-meshheading:10525313-Kinetics, pubmed-meshheading:10525313-Leukocytes, pubmed-meshheading:10525313-RNA, Messenger, pubmed-meshheading:10525313-Tumor Necrosis Factor-alpha, pubmed-meshheading:10525313-Up-Regulation
pubmed:year
1999
pubmed:articleTitle
Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation.
pubmed:affiliation
Department of Medicine and Physical Therapy, University of Tokyo School of Medicine, Tokyo, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't